The Management of Metastatic Bone Disease with the Combination of Bisphosphonates and Radiotherapy: From Theory to Clinical Practice

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|3|326-335

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.3, 2009-03, pp. : 326-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metastatic Bone Disease: Developing Strategies to Optimize Management

By Brown J.E.   Coleman R.E.  

American Journal of Cancer, Vol. 2, Iss. 4, 2003-01 ,pp. : 269-281

Adis International

Access to resources Recommend Favorite

Management of Metastatic Bone Disease and Hypercalcemia of Malignancy

By Lipton A.  

American Journal of Cancer, Vol. 2, Iss. 6, 2003-01 ,pp. : 427-438

Adis International

Access to resources Recommend Favorite

Metastatic Bone Disease: Developing Strategies to Optimize Management

By Charles S.B. Galasko  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 265-265

Adis International

Access to resources Recommend Favorite

Prognostic factors for skeletal complications from metastatic bone disease in breast cancer

By Brown Janet  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 767-779

Springer Publishing Company

Access to resources Recommend Favorite

The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite